Journal of Social Science and Human Research Studies (JSSHRS)

Generative Engine Optimization in Pharmaceutical Marketing: Benchmarking AI Search Visibility Across Commercial Therapeutics

Awulu, Isaac, Obukadata, Valentina Ochuko, Williams, Imoiboho

5 September 2026 · Vol. 2, Issue 9, pp. 1661-1680

DOI: 10.65150/EP-jsshrs/V2E9/2026-04

Abstract

Background. Generative search interfaces have become a primary channel through which patients and healthcare professionals obtain drug information. Unlike the ranked-link paradigm that governed twenty years of pharmaceutical search marketing, generative engines synthesize a single answer, name a small number of brands, and cite a narrow set of sources. A therapeutic brand that does not appear in that answer is functionally absent from the channel, regardless of its organic search position. Objective. This paper has three aims: to characterize the 2026 state of AI search visibility in health and pharmaceutical contexts using published empirical evidence; to specify a reproducible benchmarking framework for measuring the AI search visibility of commercial therapeutics across engines, languages, and therapeutic areas; and to identify the regulatory and methodological constraints that distinguish pharmaceutical Generative Engine Optimization (GEO) from GEO in unregulated commercial categories. Methods. This is a synthesis and framework paper. No primary data collection was performed. Empirical figures are drawn from published academic literature, industry citation studies, and vendor benchmark indices, each attributed in the reference list. Because pharmaceutical GEO has no mature native literature, the measurement apparatus is assembled from six adjacent fields, and Section 2.4 states those debts explicitly so that the strength of each transfer can be judged. The proposed benchmark protocol is specified at a level of detail sufficient for independent replication. Key findings from the reviewed evidence. (1) Authoritative medical sources account for a minority of AI health citations; one large-scale analysis of roughly 825,000 citations found that about 17.3 percent went to government, academic, medical-publisher, or hospital sources, while roughly three quarters went to commercial and platform domains. (2) Engines diverge sharply. The same analysis found ChatGPT directed about 24.1 percent of health citations to authoritative medical sources against about 15.1 percent for Google AI Mode, and Google's search-integrated products cited social and user-generated content four to five times more often than ChatGPT. (3) Brand-level visibility is engine-specific and language-specific to a degree that invalidates single-number reporting; one published pharmaceutical index reported a 33-percentage-point Answer Rate gap for a single dermatology brand between two engines in the same week and query set. (4) Generative engines are non-deterministic, and published bootstrap analyses show that apparent differences in citation share of fewer than roughly five to seven percentage points frequently fall inside the noise floor of single-run measurement. Conclusion. AI search visibility is measurable for pharmaceutical brands, but only as a distribution rather than a point estimate, and only when stratified by engine, language, audience, and query intent. Because generative answers routinely surface safety and off-label content outside any promotional review process, pharmaceutical GEO measurement should be treated as a pharmacovigilance and medical-legal-regulatory monitoring function as much as a marketing one.

Keywords: generative engine optimization, answer engine optimization, AI search visibility, pharmaceutical marketing, share of voice, large language models, fair balance, promotional compliance, retrieval-augmented generation

Read the full text on Journal of Social Science and Human Research Studies →The full peer-reviewed article and PDF are hosted on the journal's site (the version of record).

Awulu, Isaac, Obukadata, Valentina Ochuko, Williams, & Imoiboho (2026). Generative Engine Optimization in Pharmaceutical Marketing: Benchmarking AI Search Visibility Across Commercial Therapeutics. Journal of Social Science and Human Research Studies, 2(9), 1661-1680. https://doi.org/10.65150/EP-jsshrs/V2E9/2026-04

@article{Awulu2026,
  title   = {Generative Engine Optimization in Pharmaceutical Marketing: Benchmarking AI Search Visibility Across Commercial Therapeutics},
  author  = {Awulu and Isaac and Obukadata and Valentina Ochuko and Williams and Imoiboho},
  journal = {Journal of Social Science and Human Research Studies},
  year    = {2026},
  volume  = {2},
  number  = {9},
  pages   = {1661-1680},
  doi     = {10.65150/EP-jsshrs/V2E9/2026-04},
  url     = {https://doi.org/10.65150/EP-jsshrs/V2E9/2026-04}
}

← Back to all articles